Anandamide initiates Ca2+ signaling via CB2 receptor linked to phospholipase C in calf pulmonary endothelial cells

British Journal of Pharmacology

Volumn 140, Issue 8, 2003, Pages 1351-1362

  Zoratti, Cristina ^a   Kipmen Korgun, Dijle ^a   Osibow, Karin ^a   Malli, Roland ^a   Graier, Wolfgang F ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

Cameleon; CB2 receptor; Phospholipase C; Ratiometric pericam mt: Sr141716A; SR144528

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 2 AMINOETHOXYDIPHENYLBORANE; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; ANANDAMIDE; CALCIUM ION; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; FURA 2; INOSITOL 1,4,5 TRISPHOSPHATE; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR ANTAGONIST; PHOSPHOLIPASE C; PHOSPHOLIPASE C INHIBITOR; RIMONABANT; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CATTLE; CELL STIMULATION; CELL TYPE; CONTROLLED STUDY; CYTOSOL; DATA ANALYSIS; DRUG RECEPTOR BINDING; ENDOPLASMIC RETICULUM; ENDOTHELIUM CELL; ENZYME ACTIVATION; LUNG ENDOTHELIUM; MITOCHONDRION; MOLECULAR PROBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION;

ANIMALS; ARACHIDONIC ACIDS; BASE SEQUENCE; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM SIGNALING; CATTLE; CELL LINE; ENDOCANNABINOIDS; ENDOPLASMIC RETICULUM; ENDOTHELIUM, VASCULAR; HUMANS; MICE; MITOCHONDRIA; MOLECULAR SEQUENCE DATA; PHOSPHOLIPASE C; POLYUNSATURATED ALKAMIDES; PULMONARY ARTERY; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0347949531     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705529     Document Type: Article

References (56)

1. ASCHNER, J.L., LUM, H., FLETCHER, P.W. & MALIK, A.B. (1997). Bradykinin-and thrombin-induced increases in endothelial permeability occur independently of phospholipase C but require protein kinase C activation. J. Cell. Physiol., 173, 387-396.
2. 2+-induced relaxation in CB1 receptor-deficient mice. Hypertension, 39, 251-257.
3. CHANTAIGNEAU, T., FÉLÉTOU, M., THOLLON, C., VILLENEUVE, N., VILAINE, J.-P., DUHALT, J. & VANHOUTTE, P.M. (1998). Cannabinoid CB1 receptor and endothelium-dependent hyperpolarization in guinea-pig carotid, rat mesenteric and porcine coronary arteries. Br. J. Pharmacol., 123, 968-974.
4. CHAYTOR, A.T., MARTIN, P.E.M., EVANS, W.H., RANDALL, M.D. & GRIFFITH, T.M. (1999). The endothelial component of cannabinoid-induced relaxations in rat mesenteric artery depends on gap junctional communication but not nitric oxide. J. Physiol., 520, 539-550.
5. 2+ uptake in bovine vascular endothelial cells. J. Physiol., 539, 77-91.
6. DEUTSCH, D.G., GOLIGORSKY, M.S., SCHMID, P.C., KREBSBACH, R.J., SCHMID, H.H., DAS, S.K., DEY, S.K., ARREAZA, G., THORUP, C., STEFANO, G. & MOORE, L.C. (1997). Production and physiological actions of anandamide in the vasculature of the rat kidney. J. Clin. Invest., 100, 1538-1546.
7. DEVANE, W.A., HANUS, L., PERTWEE, R.G., STEVENSON, L.A., GRIFFIN, G., GIBSON, D., MANDELBAUM, A. & MECHOULAM, R. (1992). Isolation and structure of a brain constituent to the cannabinoid receptor. Science, 258, 1946-1949.
8. DI MARZO, V. (1998). Endocannabinoid' and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance. Biochim. Biophys. Acta., 1392, 153-175.
9. FIMIANI, C., MATTOCKS, D., CAVANI, F., SALZET, M., DEUTSCH, D., PRYOR, S., BILFINGER, T. & STEFANO, G.B. (1999). Morphine and anandamide stimulate intracellular calcium transients in human arterial endothelial cells: coupling to nitric oxide release. Cell Signal., 11, 189-193.
10. FIORIO, P.A. & MUNARON, L. (2001). Calcium influx, arachidonic acid, and control of endothelial cell proliferation. Cell Calcium, 30, 235-244.
11. Ca channel activity upon stimulation with moderate histamine concentration in a human umbilical vein endothelial cell line. J. Physiol., 540, 73-84.
12. Ca currents to hyperpolarize cultured porcine coronary artery endothelial cells. J. Physiol., 519, 361-371.
13. GALIEGUE, S., MARY, S., MARCHAND, J., DUSSOSSOY, D., CARRIERE, D., CARAYON, P., BOUABOULA, M., SHIRE, D., LE FUR, G. & CASELLAS, P. (1995). Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Em. J. Biochem., 232, 54-61.
14. 2+ channel current. Am. J. Physiol., 276, H2085-H2093.
15. GOUTOPOULOS, A., FAN, P., KHANOLKAR, A.D., XIE, X.-Q., LINA, S. & MAKRIYANNIS, A. (2001). Stereochemical selectivity of methanandamides for the CB1 and CB2 cannabinoid receptors and their metabolic stability. Bioorg. Med. Chem., 9, 1673-1684.
16. 2+ elevation beneath the cell membrane. J. Physiol., 506, 109-125.
17. 2+ -influx into cultured endothelial cells is not regulated by inositol 1,4,5-trisphosphate or inositol 1,3,4,5- tetrakisphosphate. Second Messengers Phosphoproteins, 13, 187-197.
18. HARRIS, D., MARTIN, P.E., EVANS, W.H., KENDALL, D.A., GRIFFITH, T.M. & RANDALL, M.D. (2000). Role of gap junctions in endothelium derived hyperpolarizing factor responses and mechanism of K +-relaxation. Eur. J. Pharmacol., 402, 119-128.
19. HARRIS, D., MCCULLOCH, A.I., KENDALL, D.A. & RANDALL, M.D. (2002). Characterization of vasorelaxant responses to anandamide in the rat mesenteric arterial bed. J. Physiol., 539, 893-902.
20. HOLLAND, M., CHALLIS, R.A., STANDEN, N.B. & BOYLE, J.P. (1999). Cannabinoid CB1 receptors fail to cause relaxation, but couple via Gi/Go to inhibition of adenylyl cyclase in carotid artery smooth muscle. Br. J. Pharmacol., 128, 597-604.
21. HOWLETT, A., BARTH, F., BONNER, T.I., CABRAL, G., CASELLAS, P., DEVANE, W.A., FELDER, C.C., HERKENHAM, M., MACKIE. K., MARTIN, B.R., MECHOULAM, R. & PERTWEE, R.G. (2002). International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev., 54, 161-202.
22. JARAI, Z., WAGNER, J.A., VARGA, K., LAKE, K.D., COMPTON, D.R., MARTIN, B.R., ZIMMER, A.M., BONNER, T.L., BUCKLEY, N.E., MEZEY, E., RAZDAN, R.K., ZIMMER, A. & KUNOS, G. (1999). Cannabinoid-induced mesenteric vasodilatation through an endothelial site distinct from CB1 or CB2 receptors. Proc. Natl. Acad. Sci. U.S.A. 96, 14136-14141.
23. KOGANEZAWA, M. & SHIMADA, I. (2001). Inositol 1,4,5-trisphosphate transduction cascade in taste reception of the fleshfly, Boettcherisca peregria. J. Neurobiol., 51, 66-83.
24. MACCARRONE, M., BARI, M., LORENZON, T., BISOGNO, T., DI MARZO, V. & FINAZZI-AGRO, A. (2000). Anandamide uptake by human endothelial cells and its regulation by nitric oxide. J. Biol. Chem., 275, 13484-13492.
25. 2+ elevation during agonist stimulation. J. Biol. Chem., 278, 10807-10815.
26. MATSUDA, L.A., LOLAIT, S.J., BROWNSTEIN, M.I., YOUNG, A.C. & BONNER, T.I. (1990). Structure of a cannabinoid and functional expression of the cloned cDNA. Nature, 346, 561-564.
27. 2+ signals by differential expression of IP3 receptor subtypes. EMBO J., 18, 1303-1308.
28. 2+ based on green fluorescent proteins and calmodulin. Nature, 388, 882-887.
29. 2+ in endothelial cells. Br. J. Pharmacol., 126, 1593-1600.
30. MUKHOPADHYAY, S., SHIM, J.Y., ASSI, A.A., NORFORD, D. & HOWLETT, A. (2002). CB(1) cannabinoid receptor-G protein association: a possible mechanism for differential signalling. Chem. Phys. Lipids. 121, 91-109.
31. MUNRO, S., THOMAS, K.L. & ABU-SHAAR, M. (1993). Molecular characterization of a peripheral receptor for cannabinoid. Nature, 365, 61-65.
32. NAGAI, T., IBATA, K., PARK, E.S., KUBOTA, M., MIKOSHIBA, K. & MIYAWAKI, A. (2002). A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nat. Biotechnol., 20, 87-90.
33. 2+. Proc. Natl. Acad. Sci. U.S.A., 98, 3197-3202.
34. 2+ oscillations in a human endothelial cell line depend on transmembrane ion flux, ryanodine receptor and SERCA. J. Physiol., 524, 501-514.
35. 2+ entry and nitric oxide synthase in bovine endothelial cells. J. Physiol., 513, 369-379.
36. PLANE, F., HOLLAND, M., WALDRON, G.J., GARLAND, C.J. & BOYLE, J.P. (1997). Evidence that anandamide and EDHF act via different mechanisms in rat isolated mesenteric arteries. Br. J. Pharmacol., 121, 1509-1511.
37. POZZAN, T.M., MAGALHAES, P. & RIZZATO, R. (2000a). The comeback of mitochondria to calcium signalling. Cell Calcium. 28, 279-283.
38. POZZAN, T. & RIZZATO, R. (2000b). The renaissance of mitochondrial calcium transport. Eur. J. Biochem., 267, 5269-5273.
39. PRATT, P.F., HILLARD, C.J., EDGEMOND, W.S. & CAMPBELL, W.B. (1998). N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor. Am. J. Physiol., 274, H375-H381.
40. PUTNEY, J.W. (2001). The pharmacology of capacitative calcium entry. Mol. Interv., 1, 84-94.
41. RANDALL, M.D., ALEXANDER, S.P.H., BENNETT, T., BOYD, E.A., FRY, J.R., GARDINER, S.M., KEMP, P.A., MCCULLOCH, A.I. & KENDALL, D.A. (1996). An endogenous cannabinoid as an endothelium-derived vasorelaxant. Biochem. Biophys. Res. Commun., 229, 114-120.
42. RANDALL, M.D. & KENDALL, D.A. (1997). Involvement of a cannabinoid in endothelium-derived hyperpolarizing factor-mediated coronary vasorelaxation. Eur. J. Pharmacol., 335, 205-209.
43. RINALDI-CARMONA, M., BARTH, F., HÈAULME, M., SHIRE, D., CALANDRA, B., CONGY, C., MARTINEZ, S., MARUANI, J., NEHAT, G., CAPUT, D., FERRARA, P., SOUBRIÈ, P., BRELIÈRE, J.-C. & LE FUR, G. (1994). SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett., 350, 240-244.
44. RINALDI-CARMONA, M., BARTH, F., MILLAN, J., DEROCQ, J.-M., CASELLAS, P., CONGY, C., OUSTRIC, D., SARRAN, M., BOUABOULA, M., CALANDRA, B., PORTIER, M., SHIRE, D., BRELIÈRE, J.-C. & LE FUR, G. (1998). SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. J. Pharmacol. Exp. Ther., 284, 644-650.
45. SCHMID, H.H.O. (2000). Pathways and mechanisms of N-acylethanolamine biosynthesis: can anandamide be generated selectively? Chem. Phys. Lipids. 108, 71-87.
46. SEDOVA, M. & BLATTER, L.A. (2000). Intracellular sodium modulates mitochondrial calcium signaling in vascular endothelial cells. J. Biol. Chem., 275, 35402-35407.
47. SHIRE, D., CALANDRA, B., BOUABOULA, M., BARTH, F., RINALDI-CARMONA, M., CASELLAS, P. & FERRARA, P. (1999). Cannabinoid receptor interactions with the antagonists SR 141716A and SR 144528. Life Sci., 65, 627-635.
48. SUGIURA, T., KODAKA, T., NAKANE, S., KISHIMOTO, S., KONDO, S. & WAKU, K. (1998). Detection of an endogenous cannabimimetic molecule, 2-arachidonoylglycerol, and cannabinoid CB1 receptor mRNA in human vascular cells: is 2-arachidonoylglycerol a possible vasomodulator? Biochem. Biophvs. Res. Commun., 243, 838-843.
49. 2+ release from the endoplasmic reticulum. J. Biol. Chem., 278, 15153-15161.
50. 2+ entry by nitric oxide. Br. J. Pharmacol., 137, 821-830.
51. VARGA, K., WAGNER, J.A., BRIDGEN, D.T. & KUNOS, G. (1998). Platelet-and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension. FASEB J., 12, 1035-1044.
52. VENANCE, L., SAGAN, S. & GIAUME, C. (1997). (R)-methanadamide inhibits receptor-induced calcium responses by depleting internal calcium stores in cultured astrocytes. Pflugers Arch., 434, 147-149.
53. WAGNER, J.A., VARGA, K., ELLIS, E.F., RZIGALINSKI, B.A., MARTIN, B.R. & KUNOS, G. (1997). Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock. Nature. 390, 518-521.
54. WAGNER, J.A., VARGA, K., JARAI, Z. & KUNOS, G. (1999). Mesenteric vasodilatation mediated by endothelial anandamide receptors. Hypertension, 33, 429-434.
55. WHITE, R. & HILEY, C.R. (1997). A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery. Br. J. Pharmacol., 122, 1573-1584.
56. ZYGMUNT, P.M., HOGESTATT, E.D., WALDECK, K., EDWARDS, G., KIRKUP, A.J. & WESTON, A.H. (1997). Studies on the effects of anandamide in rat hepatic artery. Br. J. Pharmacol., 122, 1679-1686.